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Drug Deaths Taskforce Recommendations 
Since the Taskforce was formed in 2019, a number of recommendations were made by the Taskforce to a range of stakeholders, 
from Government, to the First Minister and the Lord Advocate. 
These recommendations relate to a wide range of topics that the Taskforce believe would have a positive impact on tackling the 
drug problem faced in Scotland and ultimately save lives. 
Below are details of all recommendations from the creation of the Taskforce in 2019, to present. 
 Accountability and Governance Date of Recommendation 
The Taskforce recommended that Government extend the renewed leadership and call for action (from the 
National Mission) to include local leadership and organisation leads. 
12 January 2021 
 
The Taskforce highlighted the challenges faced in relation to delays in toxicology and asked for Government 
to act now to resolve this. The Taskforce will work closely with Government to develop real time monitoring 
to enable effective decision making.  
12 January 2021 
The Taskforce highlighted concerns regarding accountability and outlined that Government should hold the 
leadership of statutory services and local delivery leaders to account. This was highlighted in the Dundee 
Commission but also has been a recurring theme when communicating with ADPs. 
12 January 2021 
Assertive Outreach Date of Recommendation 
Work needs to be undertaken in identifying those not in treatment, noting the increased harm this population 
already experience, and the likely disruption to supply of drugs (during the Covid-19 pandemic). 
16 April 2020 
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Outreach support should initiate same day access to Opiate Substitution Therapy (OST) alongside provision 
of Take Home Naloxone (THN) supply. 
16 April 2020 
Outreach support should maintain therapeutic support through phone and text, particularly for those receiving 
OST unsupervised and those in self-isolation. This can be done through the ‘NHSNearMe’ technology which 
the majority of GP practices have now installed. 
16 April 2020 
The Taskforce recommends that Scottish Government make additional resources available for local 
organisations to provide service users with the means to maintain communication, e.g. mobile phones with 
credit/data packages, to ensure users can still receive a consistent level of support. 
28 July 2020 
Peer support and advocacy are instrumental in accessing appropriate services, and the Taskforce 
recommends that the Government support the development of a national peer support programme that can 
be put in place without delay. 
12 January 2021 
The Taskforce will continue to explore the use of navigators and peer support workers and make a 
recommendation on the best model for a national navigator service to support individuals to access treatment, 
including in justice settings. In the interim, the national expansion of the MAV hospital navigator programme 
should be pursued, taking a particular interest in substance use. 
6 September 2021 
Benzodiazepines Date of Recommendation 
Addressing the availability of benzodiazepines should be a key priority of this Government and the 
Taskforce would expect them to work with Police Scotland to reduce the availability of these, as well as 
supporting harm reduction initiatives 
12 January 2021 
 
Interim guidance has been produced by the Benzodiazepine Working Group. A series of consensus building 





The production of illicit pills, including atypical benzodiazepines, cause significant harm. Progress is required 
to ensure the regulation of pill presses, including a suitable licensing system to reduce related harm.  
6 September 2021 
Covid 19 Date of Recommendation 
The Taskforce highlighted the importance of maintaining service-level provision of drug and alcohol services 
during the COVID-19 outbreak and to plan for additional capacity to these services on the basis of public 
health surveillance. 
16 April 2020 
Provide risk assessment of the most vulnerable to ensure safety and that emerging needs are met at times 
when individuals need to self-isolate, or are at increased risk and subject to shielding guidelines due to 
underlying health conditions. 
16 April 2020 
Consider people who use drugs (PWUD) as a priority group. This would ensure they receive COVID-19 
testing, in particular those who are homeless/in prison/prisoners on release etc.  
16 April 2020 
Accommodation and prioritisation of rough sleepers to enable safe social distancing measures and self-
isolation amongst this population, accompanied by proactive testing for COVID-19 to allow appropriate 
measures to be put in place and ‘cohorting’ of accommodation to be considered. 
16 April 2020 
Ensure a range of in-reach services including OST and THN supply in hostels and requisitioned sites, such 
as hotels. 
16 April 2020 
Crisis and Stabilisation 
 
Date of Recommendation 
The Benzodiazepine working group of the Taskforce recommended that the Scottish Government should 
urgently consider allocating funding resources for nationally commissioned safety and stabilisation services.  
 
 
15th September 2021 
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This would include:  
o The development of appropriate pathways to embed a stabilisation service in the current and 
developing treatment and support landscape 
o Further feasibility and scoping work to cover any gaps in the existing evidence. 
o Commitment to the development of the evidence base for safety and stabilisation resource through 
lessons learned. 
Dispensing and Prescribing Date of Recommendation 
As part of the Taskforce’s recommendations on Covid (16 April 2020), the Taskforce highlighted that:  
o A rights-based approach should be taken, prioritising OST as an essential medicine.  
o Safe storage boxes should be provided for the storage of medicines and take home doses.  
o There should be ongoing availability of oral toxicology testing to those considered most at risk (e.g. 
those with unstable drug use or child protection issues) to enable accurate risk assessment around 
supervision and dispensing arrangements. 
o Home delivery outreach networks should be established - using a mixture of redeployed staff from 
other services, third sector and volunteers.  
o The use of long acting depot injection should be investigated in OST preparations, given its ability to 
aid initiatives such as self-isolation/quarantine.  
o Local formularies should be reviewed as a matter of urgency to ensure they contain the range of 
licensed, approved OST medicines (methadone, buprenorphine in its various forms, including 
injectable long-acting preparations) so that there is equity of provision and choice for patients and 
prescribers.  
o Laboratory facilities e.g. for oral fluid testing and oral toxicology testing needs to be maintained to 
ensure treatment is optimal.  
o Preparation of alternative systems of delivery should pharmacy provision be further depleted e.g. 
central stocks of OST medicines; skeleton staff to provide OST & IEP despite being closed to 
general public; expansion of outreach networks and delivery vehicles.  
16th April 2020 
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o Identify pharmacies with high patient numbers receiving OST for site-specific contingency plans to 
be developed.  
o Ensure that all health boards include OST dispensing and IEP provision as essential pharmacy 
services to be maintained as core elements of the emergency response. 
o Support pharmacies with volunteers to help manage queues.  
The Taskforce supports prescribers’ call for a review of the regulations on dispensing and prescription forms 
to take account of clinical and technological advances since implementation in 2001.  
6 September 2021 
The Taskforce recommended that the UK Government extends the temporary Covid-19 measures put in 
place to support the resilience of medicine supplies and treatment continuity, allowing Scottish Ministers to 
implement an immediate response to local emergencies within the existing legal framework. 
6 September 2021 
Diversion from Prosecution Date of Recommendation 
The Criminal Justice and the Law Subgroup is working on recommendations around diversion from 




Date of Recommendation 
Drugs checking facilities may have an important role in empowering individuals to make safe choices. They 
also potentially provide an early warning system. The Taskforce recommend the Scottish Government work 
with the Home Office to review the current drug licencing regime to ensure that it is open, transparent and 
accessible, in line with a health based approach. 
6 September 2021 
The Scottish Government should support drug testing nationally and work with local services to ensure it is 
available. 





Date of Recommendation 
The UK Government should amend the Misuse of Drugs Act 1971 or Misuse of Drugs Regulations 2000 to 
allow for the legal provision of a wider range of drug paraphernalia through harm reduction and treatment 
services, to enable safer drug consumption. 
6 September 2021 
In the interim, the Scottish Government should explore all options to support this provision. 6 September 2021 
Drug Testing and Treatment Orders (DTTOs) 
 
Date of Recommendation 
Scottish Government should review DTTOs to assess how they have been used, their outcomes and 
whether they are the most effective mechanism to support an individual’s recovery and reduce recidivism 
rates. 
 
6 September 2021 
Scottish Government should also work with the Judicial Institute to improve understanding of how to best 
support an individual’s recovery journey. 
6 September 2021 
Equality Act 2010 
 
Date of Recommendation 
A transparent review is needed of the exemption set out in S3.1 of the Equality Act 2010, (Disability) 
Regulations 2010 to explore the impact of this exemption and whether it best serves people suffering from 
addiction, what the implications of removing it and making addiction a protected characteristic would be. 
 





Date of Recommendation 
The Taskforce welcomes the engagement with its drug law reform report from family members and feel their 
contributions reflect strongly the direction and ambition of the Taskforce. The Taskforce will continue to learn 
from the projects funded and will make further recommendations on options for treatment, support and 
recovery. 
 
6 September 2021 
Funding 
 
Date of Recommendation 
The Taskforce clearly outlined in our meeting with the Minister and First Minister that additional funding 
should be made available for grass roots organisations and community-based projects alongside services to 
support vulnerable people. 
 
12 January 2021 
Information Governance 
 
Date of Recommendation 
The Taskforce outlined to the First Minister some of the challenges faced with data sharing which the 
Government must work urgently to resolve, if lifesaving interventions are to progress. 
12 January 2021 
Law Reform 
 
Date of Recommendation 
A root and branch review of the Misuse of Drugs Act is needed, taking a public health approach, and 
reforming the law to support harm reduction measures.   
6 September 2021 
If the UK Government are not willing to reform the Misuse of Drugs Act, it should commit to exploring all 
available options openly with the Scottish Government to enable Scotland to take a public health approach. 
6 September 2021 
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Meanwhile the Scottish Government should do more to maximise flexibility under the current legislation. 6 September 2021 
Further consultation should be undertaken in the second phase of the drug law reform engagement 
exploring:  
o The public’s perceptions of drug policy and opinions on what our guiding principles should be 
when developing policy and legislation.  
o People’s thoughts on relaxing the laws around drug possession offences, such as 
decriminalisation or legalisation and regulation.  
o Gauging public support for the harm reduction measures currently restricted by the Misuse of 
Drugs Act or related regulations.  
o User engagement to understand how the law impacts people’s willingness to access services. 
6 September 2021 
Lived and Living Experience 
 
Date of Recommendation 
Extend inclusion criteria for Scottish Government national helpline (0800 111 4000) for vulnerable people to 
include PWUD. 
16 April 2020 
More needs to be done to engage with those who do not currently access services. The Taskforce therefore 
recommend that a network of people with living experience is established in the next 6 months 
12 January 2021 
Medication Assisted Treatment 
 
Date of Recommendation 
The implementation of MAT Standards must be scaled up at pace. To enable this the Taskforce would 
recommend formal standards and indicators are developed by Health Improvement Scotland by the end of 
2021. Scottish Government will have a vital role in supporting this roll out by ensuring that Chief Officers 
take accountability for delivery of the standards at local level. 
12 January 2021 
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The Taskforce supports the devolution of licensing for Heroin Assisted Treatment (HAT) premises to allow 
the single-office co-ordination of premises and prescriber licensing and the Scottish Government should 
support and promote a national roll out for HAT. 
 
6 September 2021 
Naloxone  
 
Date of Recommendation 
Maximise naloxone distribution through all channels, including on release from prison and through families, 
with the possibility of using third sector organisations and recovery communities.   
16 April 2020 
Make allowance for other relevant organisations to hold/distribute naloxone during this pandemic, even if 
only for a specific timescale. 
16 April 2020 
Request that all ‘first responders’ to drug overdoses (emergency services) are naloxone trained. 16 April 2020 
Naloxone is a lifesaving drug, which the Taskforce have made significant progress in increasing its 
distribution through channels where its use can save lives. There is still capacity to increase this further, and 
this should be developed with urgency. 
12 January 2021 
The UK Government should support permanent reclassification of naloxone to make it easier to provide 
supply.  
 
6 September 2021 
In the absence of a full reclassification, the Scottish Government should work closely with the UK 
Government to ensure that the changes planned reflect the breadth of the existing statement of prosecution 
policy in Scotland. 
6 September 2021  
In the interim, the Scottish Government should also engage with the Lord Advocate in relation to the 
extension of the current statement of prosecution policy. 
6 September 2021 
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The Taskforce, at a minimum, recommends a replication of the Lord Advocate’s statement of prosecution 
policy. However, the Taskforce believes that it would be even more beneficial for naloxone to be reclassified 
from a ‘Prescription Only Medicine’ to a ‘Pharmacy’ or a ‘General Sales List’ medicine. 
 
28 September 2021 
Non-Fatal Overdose 
 
Date of Recommendation 
Non-fatal overdose pathways are vital to catching the most at-risk people early and providing them with the 
support needed to avoid a fatal overdose. The Taskforce would recommend that these should be expanded 
nationally, learning from the tests of change ongoing through the Taskforce. 
 
12 January 2021 
Policing 
 
Date of Recommendation 
Practical policing decisions, such as physical patrols can influence people’s perceptions and decisions about 
drug use and service engagement. Therefore the possibility of tolerance zones should be explored where 
police agree not to make active patrols or use stop-and-frisk powers in the vicinity of certain services 
 
6 September 2021 
The Taskforce would support consideration of the extension of Recorded Police Warnings in relation to drug 
possession offences to cover all classifications of drugs and concludes that there would be value in work by 
the Scottish Government, Police Scotland and COPFS to increase understanding of the scheme. 
 
6 September 2021 
Prison 
 
Date of Recommendation 
The Taskforce recommends that adequate throughcare provision is available to prisoners on liberation 
including: access to GP (information about the ‘Access to Healthcare – GP Registration Cards’ for 
vulnerable people accessing GPs available here - Access to Healthcare) and continuity of OST provision. 
 
16 April 2020 
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Provision of naloxone for all prisoners with a history of substance use on liberation, and their families 
(exploring distribution of intra-nasal naloxone might also be an option) is essential. 
16 April 2020 
Further work is needed to ensure holistic support is provided for people with multiple complex needs, 
including exploring the reintroduction of throughcare support officers. The Taskforce asks that options for 
sustainably funding a reinstated throughcare service are explored 
 
6 September 2021 
Scottish Government should work with the Scottish Prison Service to end Friday liberations from custody, 
implementing a blanket policy of no liberations on a Friday or in advance of a public holiday. It should also 
explore ways to support individuals released directly from custody. 
 
6 September 2021 
Further exploration of alternatives to remand and imprisonment should be considered, including bail 
supervision and residential rehabilitation. 
6 September 2021 
Public Health Surveillance 
 
Date of Recommendation 
Public Health Surveillance and the need for real-time information and data should be prioritised. This 
includes information on the impact of COVID-19 on drug related deaths, but also the impact on illicit drug 
supplies and levels of quality. This will better enable Health Boards, ADPs and service providers to provide a 
suitable response.  
 
16 April 2020 
Safer Drug Consumption Facilities 
 
Date of Recommendation 
The Taskforce supports the introduction of properly resourced safer consumption facilities in Scotland. The 
Drugs Death Taskforce recommends that the UK Government consider a legislative framework to support 
their introduction. In the interim, the Scottish Government should explore all options within the existing legal 
framework to support the delivery of safer consumption facilities. 
6 September 2021 
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The Scottish Government should also take steps to increase public understanding of such facilities. 6 September 2021 
Stigma 
 
Date of Recommendation 
Scotland should have a national and local mission statements on addressing stigmatisation – including self-
stigma, stigma by association, structural stigma and public stigma. 
 
30 July 2020 
All responses to problem drug use must be co-developed or co-produced with those who deliver services to 
people with drug problems and people with lived experience. 
30 July 2020 
All responses to problem drug use must pay specific attention to clients and groups who are most likely to 
experience stigmatisation. 
30 July 2020 
All services must help reframe the narrative around problem drug use wherever possible. Drug services should 
celebrate the success of recovery communities and focus on and communicate strong messages about the 
positive outcomes PWDP can expect when engaging with them. 
30 July 2020 
Services must actively promote opportunities for anyone – from the client group, from families and 
communities and from the workforce – to be able to challenge stigma or stigmatising behaviour, process or 
environments. 
30 July 2020 
Recommendations for journalists and editors: 
 
 Use positive imagery. 
 Adopt People first language. 
 Use your article as an opportunity to educate. 
 Always include support service information.  
 Learn about lived experience and the impact of stigma.  
30 July 2020 
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The Taskforce called for First Minister support for the Stigma Strategy and outlined that the stigma charter (in 
development) should be adopted by all public bodies and services. 
12 January 2021 
The Taskforce recommends the Scottish Government works with justice partners to support the adoption of 
the Stigma Strategy, trauma informed and family inclusive practice and the adoption of distress based 
interventions. 
6 September 2021 
Whole Systems Approach 
 
Date of Recommendation 
Access to treatment at the weekend continues to be a considerable gap in delivering a whole systems model 
of care. The Taskforce therefore recommends that Scottish Government pursue increased weekend access 
to treatment and support. 
 
12 January 2021 
Women 
 
Date of Recommendation 
The Taskforce will be making recommendations on specific support for women following the publication of its 




Date of Recommendation 
To ensure workforce capacity for injecting equipment provision (IEP), opioid substitution therapy (OST) and 
take-home naloxone (THN) delivery and ensure non-fatal overdose follow-up pathways are maintained. These 
services add value to necessary COVID-19 response measures as well as mitigate unintended consequences, 
and so prevent additional burden on the NHS.   
 
16 April 2020 
A costing exercise should be undertaken, reflecting that a push to increase the number of people in services 
must recognise the increase pressure this will put on these services and the needs that may flow from it. This 
would enable costing of a long-term sustainable system of care. This includes workforce modelling options. 














Building a skilled and motivated workforce is essential, but there has been little central investment is 
professional development. The Taskforce therefore believe that a workforce review is required. This would 
enable clear career development pathways to be defined including core skills and competencies.  
 
12 January 2021 
There is a need for a managed clinical care network, as was established in response to the Hepatitis C 
emergency. This network should include health boards and relevant professional networks 
12 January 2021 
